Enovix (NASDAQ:ENVX – Get Free Report) updated its first quarter 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of -0.210–0.150 for the period, compared to the consensus earnings per share estimate of -0.170. The company issued revenue guidance of $3.5 million-$5.5 million, compared to the consensus revenue estimate of $6.2 million.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the company. Cantor Fitzgerald restated an “overweight” rating and issued a $30.00 price target on shares of Enovix in a research note on Thursday. Janney Montgomery Scott cut Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a research note on Thursday, October 31st. Benchmark restated a “buy” rating and issued a $25.00 price target on shares of Enovix in a research note on Wednesday, October 30th. Finally, Craig Hallum decreased their price target on Enovix from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.30.
Read Our Latest Stock Analysis on Enovix
Enovix Stock Performance
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.01. Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%. The business had revenue of $9.72 million during the quarter, compared to analyst estimates of $8.77 million. Research analysts anticipate that Enovix will post -1.01 earnings per share for the current fiscal year.
Insider Buying and Selling at Enovix
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the sale, the director now owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. The trade was a 42.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 15.70% of the stock is currently owned by corporate insiders.
About Enovix
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Articles
- Five stocks we like better than Enovix
- Upcoming IPO Stock Lockup Period, Explained
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- How to Invest in Biotech Stocks
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.